Roche initially didn’t want to buy Poseida — and partner Astellas didn’t submit an offer, new filings shownews2024-12-10T14:24:56+00:00December 10th, 2024|Endpoints News|
Relation and GSK to collaborate on fibrosis, osteoarthritisnews2024-12-10T00:00:37+00:00December 10th, 2024|Endpoints News|
European Commission greenlights $16.5B Novo-Catalent acquisition news2024-12-06T18:32:53+00:00December 6th, 2024|Endpoints News|
Merck’s Eliav Barr on its LaNova deal and the unknowns of VEGF bispecificsnews2024-12-05T16:31:56+00:00December 5th, 2024|Endpoints News|
Genmab licenses second monoclonal antibody from Scancellnews2024-12-05T16:04:42+00:00December 5th, 2024|Endpoints News|
GSK’s third new pact of the week focuses on Alzheimer’s with startup Muna Therapeuticsnews2024-12-05T12:00:38+00:00December 5th, 2024|Endpoints News|
GSK, Zhifei extend shingles vaccine pact for less moneynews2024-12-05T11:40:09+00:00December 5th, 2024|Endpoints News|
Novavax sells Czech facility to Novo Nordisk for $200M to cut costsnews2024-12-04T16:18:44+00:00December 4th, 2024|Endpoints News|
GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areasnews2024-12-04T13:00:59+00:00December 4th, 2024|Endpoints News|
Dewpoint partners its ALS program, eyes JPM to raise a Series Dnews2024-12-04T13:00:06+00:00December 4th, 2024|Endpoints News|
